Guggenheim Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Buy
7,478
+245
+3% +$64.4K 0.01% 715
2026
Q1
$1.93M Buy
7,233
+1,652
+30% +$447K 0.02% 712
2025
Q4
$1.4M Sell
5,581
-303
-5% -$80.5K 0.01% 787
2025
Q3
$1.69M Sell
5,884
-834
-12% -$223K 0.01% 729
2025
Q2
$1.76M Buy
6,718
+48
+0.7% +$11.7K 0.01% 685
2025
Q1
$1.55M Sell
6,670
-738
-10% -$179K 0.01% 715
2024
Q4
$1.7M Buy
7,408
+403
+6% +$92.5K 0.01% 706
2024
Q3
$1.57M Buy
7,005
+592
+9% +$130K 0.01% 910
2024
Q2
$1.31M Sell
6,413
-1,632
-20% -$332K 0.01% 986
2024
Q1
$1.76M Buy
8,045
+131
+2% +$28.9K 0.01% 934
2023
Q4
$1.8M Sell
7,914
-4,544
-36% -$955K 0.01% 884
2023
Q3
$2.5M Buy
12,458
+143
+1% +$30.2K 0.02% 733
2023
Q2
$2.55M Sell
12,315
-12,914
-51% -$2.51M 0.02% 757
2023
Q1
$4.97M Buy
25,229
+13,911
+123% +$2.86M 0.04% 530
2022
Q4
$2.29M Sell
11,318
-5,349
-32% -$1.05M 0.02% 807
2022
Q3
$2.93M Sell
16,667
-3,493
-17% -$715K 0.03% 698
2022
Q2
$4.06M Sell
20,160
-13,004
-39% -$2.77M 0.03% 629
2022
Q1
$7.51M Sell
33,164
-9,121
-22% -$2.15M 0.05% 497
2021
Q4
$11.4M Sell
42,285
-1,977
-4% -$489K 0.06% 384
2021
Q3
$10.7M Buy
44,262
+4,261
+11% +$1.07M 0.06% 366
2021
Q2
$9.48M Buy
40,001
+14,862
+59% +$3.39M 0.06% 410
2021
Q1
$5.51M Sell
25,139
-844
-3% -$169K 0.04% 586
2020
Q4
$4.54M Buy
25,983
+13,519
+108% +$2.34M 0.03% 621
2020
Q3
$2.02M Sell
12,464
-6,539
-34% -$1.04M 0.01% 889
2020
Q2
$2.71M Buy
19,003
+1,118
+6% +$155K 0.02% 752
2020
Q1
$1.94M Sell
17,885
-2,648
-13% -$382K 0.02% 800
2019
Q4
$2.98M Sell
20,533
-3,552
-15% -$513K 0.02% 869
2019
Q3
$3.48M Sell
24,085
-7,809
-24% -$1.14M 0.03% 768
2019
Q2
$4.74M Sell
31,894
-192
-0.6% -$26.8K 0.04% 632
2019
Q1
$4.22M Sell
32,086
-20,549
-39% -$2.53M 0.03% 709
2018
Q4
$5.71M Buy
52,635
+26,744
+103% +$3.58M 0.05% 495
2018
Q3
$3.86M Buy
25,891
+4,553
+21% +$693K 0.03% 865
2018
Q2
$3.29M Sell
21,338
-275,255
-93% -$41.6M 0.02% 954
2018
Q1
$41.2M Sell
296,593
-33,204
-10% -$4.88M 0.1% 409
2017
Q4
$45.2M Buy
329,797
+12,450
+4% +$1.65M 0.11% 393
2017
Q3
$41.2M Sell
317,347
-64,766
-17% -$8.64M 0.1% 404
2017
Q2
$50.6M Buy
382,113
+2,226
+0.6% +$273K 0.13% 276
2017
Q1
$46.8M Buy
379,887
+26,325
+7% +$3.12M 0.13% 315
2016
Q4
$39M Sell
353,562
-56,741
-14% -$6.3M 0.11% 373
2016
Q3
$48.5M Sell
410,303
-10,491
-2% -$1.24M 0.15% 181
2016
Q2
$47.1M Sell
420,794
-126,856
-23% -$13.7M 0.15% 193
2016
Q1
$55.1M Sell
547,650
-84,499
-13% -$8.1M 0.17% 121
2015
Q4
$67.1M Buy
632,149
+261,643
+71% +$27M 0.2% 86
2015
Q3
$34.5M Sell
370,506
-54,144
-13% -$5.6M 0.11% 324
2015
Q2
$44.2M Buy
424,650
+44,895
+12% +$4.67M 0.11% 298
2015
Q1
$41.1M Buy
379,755
+12,947
+4% +$1.33M 0.1% 365
2014
Q4
$34M Buy
366,808
+49,757
+16% +$4.39M 0.09% 437
2014
Q3
$27.7M Buy
317,051
+50,106
+19% +$4.53M 0.07% 509
2014
Q2
$23.5M Buy
266,945
+8,501
+3% +$736K 0.06% 581
2014
Q1
$21.8M Buy
258,444
+9,118
+4% +$727K 0.06% 569
2013
Q4
$19.6M Buy
249,326
+41,762
+20% +$3.56M 0.06% 583
2013
Q3
$17.7M Buy
207,564
+57,139
+38% +$4.81M 0.06% 532
2013
Q2
$12.9M Buy
+150,425
New +$12.5M 0.05% 629

Other funds holding LH

Guggenheim Capital's LH Position: Q2 2026 in Review

Guggenheim Capital increased its Labcorp (LH) stake by 3.4% in Q2 2026, buying an estimated $64.4K and bringing the position to 7,478 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #715.

Guggenheim Capital first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.1M in Q4 2015. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Guggenheim Capital held 7,478 shares of Labcorp worth $2.09M as of Q2 2026.
  • Guggenheim Capital bought 245 Labcorp shares in Q2 2026, an estimated $64.4K.
  • Labcorp made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #715 holding.
  • Guggenheim Capital first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's Labcorp position peaked at $67.1M in Q4 2015.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.